Successes and challenges of China's health care reform: a four-decade perspective spanning 1985-2023.

Jakovljevic, Mihajlo; Chang, Hanyu; Pan, Jay; Guo, Chao; Hui, Jin; Hu, Hao; Grujic, Danko; Li, Zhong; Shi, Lizheng

Jakovljevic, Mihajlo; Chang, Hanyu; Pan, Jay; Guo, Chao; Hui, Jin; Hu, Hao; Grujic, Danko; Li, Zhong; Shi, Lizheng.

Afiliação

Jakovljevic M; Institute of Comparative Economic Studies, Hosei University Faculty of Economics, Tokyo, Japan. jakovljevic.mihajlo.46@hosei.ac.jp.
Chang H; Department of Global Health Economics and Policy, University of Kragujevac, 34000, Kragujevac, Serbia. jakovljevic.mihajlo.46@hosei.ac.jp.
Pan J; Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, Saint Petersburg, Russian Federation. jakovljevic.mihajlo.46@hosei.ac.jp.
Guo C; Department of Medical Insurance, The First Hospital of Lanzhou University, Lanzhou, China.
Hui J; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Hu H; School of Public Administration, Sichuan University, Chengdu, China.
Grujic D; Institute of Population Research, Peking University, Beijing, China.
Li Z; School of Economics and Management, Zhejiang Sci-Tech University, Hangzhou, China.
Shi L; Institute of Chinese Medical Sciences, University of Macau, Macao, SAR, China.

Cost Eff Resour Alloc ; 21(1): 59, 2023 Aug 30.

Article em En | MEDLINE | ID: mdl-37649062

Palavras-chave

Chinese health reform; Demand; Industry; Insurance policy; Manufacturing; Market; Medical care; Medical devices; Perspective; Pharmaceuticals; Standards; Supply

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Equidade_desigualdade Bases de dados: MEDLINE Aspecto: Equity_inequality Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google